Obesity hypertension: the rationale for renin-angiotensin system blockade

Hong Kong Med J. 2005 Jun;11(3):217-20.
No abstract available

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / prevention & control
  • Humans
  • Hypertension / drug therapy*
  • Insulin Resistance
  • Obesity / complications*
  • Obesity / metabolism
  • Renin-Angiotensin System / drug effects*
  • Renin-Angiotensin System / physiology

Substances

  • Antihypertensive Agents